1. Home
  2. PACS vs PTCT Comparison

PACS vs PTCT Comparison

Compare PACS & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PACS Group Inc.

PACS

PACS Group Inc.

HOLD

Current Price

$37.82

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$72.08

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACS
PTCT
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.7B
IPO Year
2024
2006

Fundamental Metrics

Financial Performance
Metric
PACS
PTCT
Price
$37.82
$72.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
17
Target Price
$45.50
$80.65
AVG Volume (30 Days)
855.6K
1.4M
Earning Date
02-26-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
221.05
264.48
EPS
0.50
N/A
Revenue
$5,288,932,000.00
$264,734,000.00
Revenue This Year
$10.19
N/A
Revenue Next Year
$8.58
$17.70
P/E Ratio
$79.24
N/A
Revenue Growth
29.32
36.19
52 Week Low
$7.50
$43.18
52 Week High
$43.08
$87.50

Technical Indicators

Market Signals
Indicator
PACS
PTCT
Relative Strength Index (RSI) 57.26 53.41
Support Level $36.98 $61.59
Resistance Level $42.29 $79.67
Average True Range (ATR) 1.94 3.55
MACD 0.67 0.59
Stochastic Oscillator 55.71 49.85

Price Performance

Historical Comparison
PACS
PTCT

About PACS PACS Group Inc.

PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: